Market Cap:
24h Vol:
Cryptocurrencies: 2863
Markets: 94965
Home Blog Fear & Greed Pools Wallets Dictionary Advertise Best Betting Sites in Nigeria
ENG
USD
USD
NGN
AED
AFN
ALL
AMD
ANG
AOA
ARS
AUD
AWG
AZN
BAM
BBD
BDT
BGN
BHD
BIF
BMD
BND
BOB
BRL
BTN
BWP
BYN
BZD
CAD
CDF
CHF
CLF
CLP
CNH
CNY
COP
CRC
CUC
CUP
CVE
CZK
DJF
DKK
DOP
DZD
EGP
ERN
ETB
EUR
FJD
FKP
GBP
GEL
GHS
GIP
GMD
GNF
GTQ
GYD
HKD
HNL
HRK
HTG
HUF
IDR
ILS
IMP
INR
ISK
JMD
JOD
JPY
KES
KGS
KHR
KMF
KPW
KRW
KWD
KYD
KZT
LAK
LBP
LKR
LRD
LSL
LYD
MAD
MDL
MGA
MKD
MMK
MNT
MOP
MRU
MUR
MVR
MWK
MXN
MYR
MZN
NAD
NIO
NOK
NPR
NZD
OMR
PAB
PEN
PGK
PHP
PKR
PLN
PYG
QAR
RON
RSD
RUB
RWF
SAR
SBD
SCR
SDG
SEK
SGD
SHP
SLL
SRD
SSP
STD
STN
SVC
SYP
SZL
THB
TJS
TMT
TND
TOP
TRY
TTD
TWD
TZS
UAH
UGX
UYU
UZS
VES
VND
VUV
WST
ZAR
ZMW
ZWL
Market Cap:
24h Vol:
Cryptocurrencies: 2863
Bitcoin Bitcoin Share: 57.81%
Markets: 94965
Coin Edition
2023-01-31 10:55:00

VitaDAO Raises $4.1 Million From Pfizer, Coinbase CTO

VitaDAO Raises $4.1 Million From Pfizer, Coinbase CTO

Decentralized Science (DeSci) startup VitaDAO has raised $4.1 million in a funding round that saw participation from Retro Biosciences CEO Joe Betts-LaCroix, Coinbase CTO Balaji Srinivasan, and the venture investment arm of pharmaceutical giant Pfizer. Shine Capital, L1 Digital, and fellow DeSci outfits SpaceshipDAO and BeakerDAO also invested in the latest round. According to a The post VitaDAO Raises $4.1 Million From Pfizer, Coinbase CTO appeared first on Coin Edition .

Most Read News

Related News

_
_
Get Crypto Newsletter
Market Cap
24h Vol
57.81%
Bitcoin Share
0
Today News
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.